U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 180

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr7:140453135-140453136
GRCh38:
Chr7:140753335-140753336
BRAFV512D, V548D, V563D, V566D, V578D, V600D, V603D, V640DMelanomaUncertain significance
(Mar 28, 2023)
no assertion criteria provided
2.
GRCh37:
Chr2:25463248
GRCh38:
Chr2:25240379
DNMT3AR749C, R597C, R526C, R560CTatton-Brown-Rahman overgrowth syndromePathogenic
(Aug 16, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr13:32910555
GRCh38:
Chr13:32336418
BRCA2Y688CMelanoma, Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Mar 23, 2023)
criteria provided, conflicting interpretations
4.
GRCh37:
Chr9:21971161
GRCh38:
Chr9:21971162
CDKN2AH66P, H15PMelanoma, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr7:6426892
GRCh38:
Chr7:6387261
RAC1P29SMalignant neoplasm of body of uterus, Squamous cell carcinoma of the skin, Malignant melanoma of skin,
Squamous cell carcinoma of the head and neck
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
6.
GRCh37:
Chr1:11184580
GRCh38:
Chr1:11124523
MTORP2213SMelanomanot provided
(Mar 10, 2016)
no assertion provided
7.
GRCh37:
Chr1:11188519
GRCh38:
Chr1:11128462
MTORH1968YMelanomanot provided
(Mar 10, 2016)
no assertion provided
8.
GRCh37:
Chr7:140481411
GRCh38:
Chr7:140781611
BRAFG466A, G378A, G414A, G429A, G432A, G444A, G469A, G506AMelanoma, Malignant melanoma of skin, Neoplasm of the large intestine,
Multiple myeloma, Squamous cell lung carcinoma, Lung adenocarcinoma,
Squamous cell carcinoma of the head and neck
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
9.
GRCh37:
Chr7:140453151
GRCh38:
Chr7:140753351
BRAFF595S, F507S, F543S, F558S, F561S, F573S, F598S, F635SMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
10.
GRCh37:
Chr7:140453137
GRCh38:
Chr7:140753337
BRAFV600L, V512L, V548L, V563L, V566L, V578L, V603L, V640LCardiofaciocutaneous syndrome 1Pathogenic/Likely pathogeniccriteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr7:140453136
GRCh38:
Chr7:140753336
BRAFV600A, V512A, V548A, V563A, V566A, V578A, V603A, V640AMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
12.
GRCh37:
Chr7:140453132-140453134
GRCh38:
Chr7:140753332-140753334
BRAFK601del, K513del, K549del, K564del, K567del, K579del, K604del, K641delMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
13.
GRCh37:
Chr7:140453132
GRCh38:
Chr7:140753332
BRAFK601N, K513N, K549N, K564N, K567N, K579N, K604N, K641NRASopathyUncertain significance
(Oct 13, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr7:140453132
GRCh38:
Chr7:140753332
BRAFK601N, K513N, K549N, K564N, K567N, K579N, K604N, K641NMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
15.
GRCh37:
Chr7:140453121-140453122
GRCh38:
Chr7:140753321-140753322
BRAFS605F, S517F, S553F, S568F, S571F, S583F, S608F, S645FMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
16.
GRCh37:
Chr7:140453121
GRCh38:
Chr7:140753321
BRAFS605N, S517N, S553N, S568N, S571N, S583N, S608N, S645NMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
17.
GRCh37:
Chr4:55599348
GRCh38:
Chr4:54733182
KITV825A, V821A, V820A, V822A, V824A, V826AMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
18.
GRCh37:
Chr3:41266122
GRCh38:
Chr3:41224631
CTNNB1, LOC126806658T40I, T33IMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
19.
GRCh37:
Chr3:41266098
GRCh38:
Chr3:41224607
CTNNB1, LOC126806658D32A, D25ANeoplasm of uterine cervix, Melanoma, Gastric adenocarcinoma,
Prostate adenocarcinoma, Malignant neoplasm of body of uterus, Malignant melanoma of skin,
Hepatocellular carcinoma, Medulloblastoma, Transitional cell carcinoma of the bladder
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
20.
GRCh37:
Chr3:41266074-41266097
GRCh38:
Chr3:41224583-41224606
CTNNB1, LOC126806658MelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
21.
GRCh37:
Chr3:41266068
GRCh38:
Chr3:41224577
CTNNB1, LOC126806658V22A, V15AMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
22.
GRCh37:
Chr3:41266066-41266116
GRCh38:
Chr3:41224575-41224625
CTNNB1, LOC126806658MelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
23.
GRCh37:
Chr3:41266064
GRCh38:
Chr3:41224573
CTNNB1, LOC126806658A21T, A14TMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
24.
GRCh37:
Chr3:41266040
GRCh38:
Chr3:41224549
CTNNB1, LOC126806658A13T, A6TMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
25.
GRCh37:
Chr1:115256529-115256530
GRCh38:
Chr1:114713908-114713909
NRASQ61RMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
26.
GRCh37:
Chr3:12641195
GRCh38:
Chr3:12599696
RAF1W368S, W287S, W388S, W307S, W335S, W254SMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
27.
GRCh37:
Chr4:55152126
GRCh38:
Chr4:54285959
PDGFRAG853D, G866D, G878DGastrointestinal stroma tumorUncertain significance
(Feb 9, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr4:55152101
GRCh38:
Chr4:54285934
PDGFRAH845Y, H858Y, H870YMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
29.
GRCh37:
Chr4:55152090
GRCh38:
Chr4:54285923
PDGFRAR841K, R854K, R866KMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
30.
GRCh37:
Chr4:55144144
GRCh38:
Chr4:54277977
PDGFRAV658A, V671A, V683AMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
31.
GRCh37:
Chr4:55141083
GRCh38:
Chr4:54274916
PDGFRAP577S, P602S, P590SMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
32.
GRCh37:
Chr19:4117617
GRCh38:
Chr19:4117619
MAP2K2V35MMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
33.
GRCh37:
Chr19:4117584
GRCh38:
Chr19:4117586
MAP2K2L46FMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
34.
GRCh37:
Chr19:4117541
GRCh38:
Chr19:4117543
MAP2K2Q60PMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
35.
GRCh37:
Chr19:4110584
GRCh38:
Chr19:4110586
MAP2K2C125SMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
36.
GRCh37:
Chr19:4110581
GRCh38:
Chr19:4110583
MAP2K2N126DCardiofaciocutaneous syndrome 4, RASopathyPathogenic/Likely pathogenic
(Aug 19, 2021)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr15:66729177
GRCh38:
Chr15:66436839
MAP2K1F129LMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
38.
GRCh37:
Chr15:66727455
GRCh38:
Chr15:66435117
MAP2K1K57NMelanoma, Prostate adenocarcinoma, Gastric adenocarcinoma,
Malignant melanoma of skin, Lung adenocarcinoma, Non-Hodgkin lymphoma,
Squamous cell carcinoma of the head and neck
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
39.
GRCh37:
Chr15:66727453
GRCh38:
Chr15:66435115
MAP2K1K57EMelanoma, MelorheostosisPathogenic/Likely pathogenic
(Jun 23, 2020)
no assertion criteria provided
40.
GRCh37:
Chr2:212570064
GRCh38:
Chr2:211705339
ERBB4R393WMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
41.
GRCh37:
Chr2:212537981
GRCh38:
Chr2:211673256
ERBB4E542KMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
42.
GRCh37:
Chr2:212295699
GRCh38:
Chr2:211430974
ERBB4E872KMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
43.
GRCh37:
Chr7:140453133
GRCh38:
Chr7:140753333
BRAFK601R, K513R, K549R, K564R, K567R, K579R, K604R, K641RMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
44.
GRCh37:
Chr14:105243048
GRCh38:
Chr14:104776711
AKT1Q79KMelanomaLikely pathogenic
(Dec 26, 2014)
no assertion criteria provided
45.
GRCh37:
Chr7:140481478
GRCh38:
Chr7:140781678
BRAFR444W, R356W, R392W, R407W, R410W, R422W, R447W, R484WMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
46.
GRCh37:
Chr7:140481411
GRCh38:
Chr7:140781611
BRAFG466E, G378E, G414E, G429E, G432E, G444E, G469E, G506ENoonan syndrome 7, RASopathyConflicting interpretations of pathogenicity
(Jan 23, 2023)
criteria provided, conflicting interpretations
47.
GRCh37:
Chr7:140481402-140481403
GRCh38:
Chr7:140781602-140781603
BRAFG469S, G381S, G417S, G432S, G435S, G447S, G472S, G509SMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
48.
GRCh37:
Chr7:140453161
GRCh38:
Chr7:140753361
BRAFI592V, I504V, I540V, I555V, I558V, I570V, I595V, I632VMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
49.
GRCh37:
Chr7:140453154
GRCh38:
Chr7:140753354
BRAFD594A, D506A, D542A, D557A, D560A, D572A, D597A, D634AMelanomaLikely pathogenic
(Oct 2, 2014)
no assertion criteria provided
50.
GRCh37:
Chr7:140453135-140453136
GRCh38:
Chr7:140753335-140753336
BRAFV600E, V512E, V548E, V563E, V566E, V578E, V603E, V640EMelanoma, Colonic neoplasmLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
51.
GRCh37:
Chr4:55594258
GRCh38:
Chr4:54728092
KITV654E, V650E, V651E, V655EMelanomaLikely pathogenic
(Oct 2, 2014)
no assertion criteria provided
52.
GRCh37:
Chr3:41266097
GRCh38:
Chr3:41224606
CTNNB1, LOC126806658D32H, D25HNeoplasm of uterine cervix, Prostate adenocarcinoma, Malignant neoplasm of body of uterus,
Gastric adenocarcinoma, Malignant melanoma of skin, Medulloblastoma,
Melanoma, Hepatocellular carcinoma, Transitional cell carcinoma of the bladder
Likely pathogenic
(May 31, 2016)
no assertion criteria provided
53.
GRCh37:
Chr1:115258730
GRCh38:
Chr1:114716109
NRASA18TMelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
54.
GRCh37:
Chr1:115256530
GRCh38:
Chr1:114713909
NRASQ61*MelanomaLikely pathogenic
(Jul 14, 2015)
no assertion criteria provided
55.
GRCh37:
Chr19:3118942
GRCh38:
Chr19:3118944
GNA11Q209Lnot provided, See casesPathogenic/Likely pathogenic
(Dec 5, 2021)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr19:3118942
GRCh38:
Chr19:3118944
GNA11Q209PMelanoma, Uveal melanomaPathogenic/Likely pathogenic
(Jul 14, 2015)
no assertion criteria provided
57.
GRCh37:
Chr15:66782915
GRCh38:
Chr15:66490577
MAP2K1, SNAPC5N382H, N334HMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
58.
GRCh37:
Chr15:66777424
GRCh38:
Chr15:66485086
MAP2K1P264SMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
59.
GRCh37:
Chr15:66774131
GRCh38:
Chr15:66481793
MAP2K1E203KInborn genetic diseases, Cardiofaciocutaneous syndrome 3Likely pathogenic
(Jul 2, 2018)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr15:66729162
GRCh38:
Chr15:66436824
MAP2K1P124SRASopathyPathogenic
(Jul 2, 2020)
reviewed by expert panel
FDA Recognized Database
61.
GRCh37:
Chr15:66729154
GRCh38:
Chr15:66436816
MAP2K1C121SMelanoma, Lung adenocarcinomaPathogenic/Likely pathogenic
(Jul 14, 2015)
no assertion criteria provided
62.
GRCh37:
Chr15:66729124
GRCh38:
Chr15:66436786
MAP2K1I111SMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
63.
GRCh37:
Chr15:66727451
GRCh38:
Chr15:66435113
MAP2K1Q56Pnot providedPathogenic
(Jul 2, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr15:66727441
GRCh38:
Chr15:66435103
MAP2K1F53LMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
65.
GRCh37:
Chr9:80409488
GRCh38:
Chr9:77794572
GNAQQ209PMelanoma, Uveal melanomaPathogenic/Likely pathogenic
(Jul 14, 2015)
no assertion criteria provided
66.
GRCh37:
Chr9:80409488
GRCh38:
Chr9:77794572
GNAQQ209RMelanoma, Abnormal cardiovascular system morphologyPathogenic
(Oct 2, 2014)
no assertion criteria provided
67.
GRCh37:
Chr9:80409488
GRCh38:
Chr9:77794572
GNAQQ209LMelanoma, Uveal melanomaPathogenic/Likely pathogenic
(Jul 14, 2015)
no assertion criteria provided
68.
GRCh37:
Chr7:140453155-140453156
GRCh38:
Chr7:140753355-140753356
BRAFD594N, D506N, D542N, D557N, D560N, D572N, D597N, D634NMelanoma, Gallbladder cancerPathogenic/Likely pathogenic
(Oct 30, 2020)
no assertion criteria provided
69.
GRCh37:
Chr7:140453155
GRCh38:
Chr7:140753355
BRAFD594H, D506H, D542H, D557H, D560H, D572H, D597H, D634HNeoplasm of the large intestine, Adrenal cortex carcinoma, Chronic lymphatic leukemia,
Neoplasm of brain, Multiple myeloma, Malignant melanoma of skin,
Lung adenocarcinoma, Squamous cell carcinoma of the head and neck, Melanoma,
Transitional cell carcinoma of the bladder
Pathogenic/Likely pathogenic
(May 31, 2016)
no assertion criteria provided
70.
GRCh37:
Chr7:140453154
GRCh38:
Chr7:140753354
BRAFD594V, D506V, D542V, D557V, D560V, D572V, D597V, D634VRASopathyPathogenic
(May 18, 2020)
reviewed by expert panel
FDA Recognized Database
71.
GRCh37:
Chr7:140453153
GRCh38:
Chr7:140753353
BRAFD594E, D506E, D542E, D557E, D560E, D572E, D597E, D634EMelanomaPathogenic
(Jul 14, 2015)
no assertion criteria provided
72.
GRCh37:
Chr7:140453153
GRCh38:
Chr7:140753353
BRAFD594E, D506E, D542E, D557E, D560E, D572E, D597E, D634EMelanoma, Cardio-facio-cutaneous syndromePathogenic/Likely pathogenic
(Oct 2, 2014)
no assertion criteria provided
73.
GRCh37:
Chr7:140453149
GRCh38:
Chr7:140753349
BRAFG596R, G508R, G544R, G559R, G562R, G574R, G599R, G636RMultiple myeloma, Melanoma, Neoplasm of the large intestine,
Glioblastoma, Transitional cell carcinoma of the bladder, Lung adenocarcinoma
Pathogenic/Likely pathogenic
(May 31, 2016)
no assertion criteria provided
74.
GRCh37:
Chr7:140453145-140453146
GRCh38:
Chr7:140753345-140753346
BRAFL597S, L509S, L545S, L560S, L563S, L575S, L600S, L637SMelanomaPathogenic
(Jul 14, 2015)
no assertion criteria provided
75.
GRCh37:
Chr7:140453136-140453137
GRCh38:
Chr7:140753336-140753337
BRAFV600K, V512K, V548K, V563K, V566K, V578K, V603K, V640KTrametinib-Dabrafenib Response, Vemurafenib-Cobimetinib Responsedrug responsecriteria provided, single submitter
76.
GRCh37:
Chr7:140453136-140453137
GRCh38:
Chr7:140753336-140753337
BRAFV600R, V512R, V548R, V563R, V566R, V578R, V603R, V640RMelanomaPathogenic
(Jul 14, 2015)
no assertion criteria provided
77.
GRCh37:
Chr7:140453135-140453136
GRCh38:
Chr7:140753335-140753336
BRAFV600D, V512D, V548D, V563D, V566D, V578D, V603D, V640DMelanomaPathogenic
(Jul 14, 2015)
no assertion criteria provided
78.
GRCh37:
Chr4:55602664
GRCh38:
Chr4:54736498
KITA829P, A825P, A824P, A826P, A828P, A830PGastrointestinal stroma tumor, MelanomaPathogenic/Likely pathogenic
(Dec 26, 2014)
no assertion criteria provided
79.
GRCh37:
Chr4:55599340
GRCh38:
Chr4:54733174
KITN822K, N818K, N817K, N819K, N821K, N823Knot providedPathogenic
(Jan 8, 2015)
criteria provided, single submitter
80.
GRCh37:
Chr4:55599340
GRCh38:
Chr4:54733174
KITN822K, N818K, N817K, N819K, N821K, N823Knot provided, Gastrointestinal stroma tumorConflicting interpretations of pathogenicity
(Aug 30, 2021)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr4:55599339
GRCh38:
Chr4:54733173
KITN822I, N818I, N817I, N819I, N821I, N823ICutaneous mastocytosis, Gastrointestinal stroma tumor, Melanoma
Pathogenic/Likely pathogenic
(Jun 25, 2018)
no assertion criteria provided
82.
GRCh37:
Chr4:55599332
GRCh38:
Chr4:54733166
KITD820Y, D816Y, D815Y, D817Y, D819Y, D821YMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
83.
GRCh37:
Chr4:55599332
GRCh38:
Chr4:54733166
KITD820H, D816H, D815H, D817H, D819H, D821HMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
84.
GRCh37:
Chr4:55594262
GRCh38:
Chr4:54728096
KITN655K, N651K, N652K, N656KGastrointestinal stroma tumorLikely pathogenic
(Aug 12, 2021)
criteria provided, single submitter
85.
GRCh37:
Chr4:55594262
GRCh38:
Chr4:54728096
KITN655K, N651K, N652K, N656KGastrointestinal stroma tumorPathogenic
(Sep 1, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr4:55594261
GRCh38:
Chr4:54728095
KITN655S, N651S, N652S, N656SGastrointestinal stroma tumorUncertain significance
(May 22, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr4:55594258
GRCh38:
Chr4:54728092
KITV654A, V650A, V651A, V655AGastrointestinal stroma tumorUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
88.
GRCh37:
Chr4:55593661
GRCh38:
Chr4:54727495
KITL576P, L572P, L573P, L577PGastrointestinal stroma tumor, Hereditary cancer-predisposing syndromePathogenic/Likely pathogenic
(Sep 7, 2021)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr4:55593640
GRCh38:
Chr4:54727474
KITV569G, V565G, V566G, V570GMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
90.
GRCh37:
Chr4:55593630
GRCh38:
Chr4:54727464
KITN566D, N562D, N563D, N567DMelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
91.
GRCh37:
Chr4:55593613
GRCh38:
Chr4:54727447
KITV560G, V556G, V557G, V561GMelanoma, Gastrointestinal stroma tumorPathogenic/Likely pathogenic
(May 13, 2016)
no assertion criteria provided
92.
GRCh37:
Chr4:55593613
GRCh38:
Chr4:54727447
KITV560A, V556A, V557A, V561AGastrointestinal stroma tumorUncertain significance
(Aug 31, 2021)
criteria provided, single submitter
93.
GRCh37:
Chr4:55593613
GRCh38:
Chr4:54727447
KITV560D, V556D, V557D, V561DMelanoma, Gastrointestinal stroma tumorPathogenic/Likely pathogenic
(May 13, 2016)
no assertion criteria provided
94.
GRCh37:
Chr4:55593609-55593611
GRCh38:
Chr4:54727443-54727445
KITV560del, V556del, V557del, V561delThymoma, Melanoma, Gastrointestinal stromal tumor, familial
Pathogenic/Likely pathogenic
(Jul 14, 2015)
no assertion criteria provided
95.
GRCh37:
Chr4:55593610
GRCh38:
Chr4:54727444
KITV559G, V555G, V556G, V560GMelanoma, Gastrointestinal stroma tumorPathogenic/Likely pathogenic
(May 13, 2016)
no assertion criteria provided
96.
GRCh37:
Chr4:55593608
GRCh38:
Chr4:54727442
KITK558N, K554N, K555N, K559NGastrointestinal stroma tumor, MelanomaPathogenic/Likely pathogenic
(May 13, 2016)
no assertion criteria provided
97.
GRCh37:
Chr4:55593608
GRCh38:
Chr4:54727442
KITK558N, K554N, K555N, K559NGastrointestinal stroma tumorUncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr4:55593603
GRCh38:
Chr4:54727437
KITW557R, W553R, W554R, W558RHereditary cancer-predisposing syndrome, Gastrointestinal stroma tumorPathogenic/Likely pathogenic
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr4:55593603
GRCh38:
Chr4:54727437
KITW557R, W553R, W554R, W558RGastrointestinal stroma tumor, MelanomaPathogenic/Likely pathogenic
(May 13, 2016)
no assertion criteria provided
100.
GRCh37:
Chr4:55593591
GRCh38:
Chr4:54727425
KITY553N, Y549N, Y550N, Y554NThymoma, MelanomaPathogenic
(Oct 2, 2014)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination